Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis
Open Access
- 1 August 2004
- journal article
- research article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 2 (8), 1305-1310
- https://doi.org/10.1046/j.1538-7836.2004.00855.x
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosisBlood, 2004
- Bimodal distribution of soluble endothelial protein C receptor levels in healthy populationsJournal of Thrombosis and Haemostasis, 2003
- Inherited Abnormalities in the protein C Activation PathwayPathophysiology of Haemostasis and Thrombosis, 2002
- Factor V Antigen Levels and Venous ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Mechanisms by Which Soluble Endothelial Cell Protein C Receptor Modulates Protein C and Activated Protein C FunctionPublished by Elsevier BV ,2000
- Metalloproteolytic Release of Endothelial Cell Protein C ReceptorPublished by Elsevier BV ,2000
- Allelic discrimination using fluorogenic probes and the 5′ nuclease assayGenetic Analysis: Biomolecular Engineering, 1999
- Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutationThe Lancet, 1994
- John Hageman's factor and deep‐vein thrombosis: Leiden Thrombophilia StudyBritish Journal of Haematology, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993